Niacin: A powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11883-003-0014-1.pdf
Reference22 articles.
1. Kreisberg RA: Niacin: a therapeutic dilemma. “One man’s drink is another’s poison.” Am J Med 1994, 97:313–316.
2. Guyton JR: Effect of niacin on atherosclerotic cardiovascular disease. Am J Cardiol 1998, 82:18U-23U.
3. Capuzzi DM, Guyton JR, Morgan JM, et al.: Efficacy and safety of an extended-release niacin (Niaspan): a long-term study. Am J Cardiol 82:74U–81U.
4. Jin FY, Kamanna VS, Kashyap ML: Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport. Arterioscler Thromb Vasc Biol 1997, 17:2020–2028.
5. Gray DR, Morgan T, Chretien SD, et al.: Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans. Ann Intern Med 1994, 121:252–258.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis and antihyperlipidemic activity of some novel 4-substituted-2-substitutedmethyltriazino[6,1-b]quinazolin-10-ones and 2,4-disubstituted-6,7-dimethoxy quinazoline;Arabian Journal of Chemistry;2016-09
2. Improved Cardiac Management with a Disease Management Program Incorporating Comprehensive Lipid Profiling;Population Health Management;2012-02
3. Extended Release Niacin-Laropiprant in Patients with Hypercholesterolemia or Mixed Dyslipidemias Improves Clinical Parameters;Clinical Medicine Insights: Cardiology;2011-01
4. Lipoprotein(a): From Molecules to Therapeutics;American Journal of Therapeutics;2010-05
5. Elevated Lipoprotein(a)—A Genetic Risk Factor for Premature Vascular Disease in People With and Without Standard Risk Factors: A Review;Disease-a-Month;2006-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3